Stefanie Mason

7PUBLICATIONS
37CO-AUTHORS
Gene and molecular therapyRespiratory diseasesEpidemiological methodsExercise physiologyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 01, 2026
Cardiac Safety Outcomes in Delandistrogene Moxeparvovec Clinical Trials for Duchenne Muscular Dystrophy with Up to 5 Years of Follow-up.

|Jun 04, 2026
Five-Year Outcomes With Delandistrogene Moxeparvovec in Patients With Duchenne Muscular Dystrophy: A Phase 1/2a Study.

|Sep 21, 2021
Loss of Pulmonary Vascular Volume as a Predictor of Right Ventricular Dysfunction and Mortality in Acute Pulmonary Embolism.

Jasleen Minhas, Pietro Nardelli, Syed Moin Hassan

|Feb 16, 2021
Relationship between Emphysema Progression at CT and Mortality in Ever-Smokers: Results from the COPDGene and ECLIPSE Cohorts.

Samuel Y Ash, Raúl San José Estépar, Sean B Fain

|Feb 12, 2021
Respiratory exacerbations are associated with muscle loss in current and former smokers.

Stefanie Elizabeth Mason, Rafael Moreta-Martinez, Wassim W Labaki

|Feb 13, 2020
Cost-effectiveness microsimulation of catheter-directed thrombolysis in submassive pulmonary embolism using a right ventricular function model.

Stefanie E Mason, Jinyi Zhu, Farbod N Rahaghi

Pageof 2

Frequent Collaborators

2 joint publications

Samuel Y Ash

2 joint publications

Raúl San José Estépar

2 joint publications

Craig M McDonald

2 joint publications

Gonzalo Vegas-Sánchez-Ferrero